Home \ How to use Mexidol®: tablets and injections of ethylmethylhydroxypyridine succinate solution

How to apply Mexidol®

Administration regimens

Mexidol® is effectively used in both adults and children aged 6 years and older.
Select your indication from the drop-down list below, and you will be shown the recommended treatment regimen.

Indications ¹

Attention deficiency syndrome (HDVG) in children, including hyperactivity, impaired attention, impulsivity^2,4

The presence of injection and tablet dosage forms of Mexidol® allows for consistent therapy, and a wide range of doses - to apply an individual approach to each patient, revealing the maximum therapeutic potential of the drug.

Forms of release

2 ml No. 10

5 ml No. 5

5 ml No. 10

Mexidol® solution, for intravenous
and intramuscular administration 50 mg/ml

1 ml contains 50 mg of the active substance

Order online General characteristics
of the medicinal product Package leaflet

Indications ¹

acute cerebral circulation disorders;
cerebral infarction (ischemic stroke);
traumatic brain injury, consequences of traumatic brain injury;
dyscirculatory encephalopathy;
Chronic cerebral ischemia;
Vegetative dystonia syndrome;
Mild (moderate) cognitive disorders;
Anxiety disorders in neurotic and neurosis-like states;
acute myocardial infarction (from the first day) as part of complex therapy;
primary open -angle glaucoma of various stages, as part of complex therapy;
withdrawal syndrome in alcoholism with predominance of neurosis-like and vegetative-vascular disorders;
acute intoxication with antipsychotic drugs;
acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis) as part of complex therapy.

№30

№50

Mexidol® tablets covered with a film shell 125 mg

1 tablet contains 125 mg of the active ingredient

Approved for children of 6 years of age and older

Order online General characteristics
of the medicinal product Package leaflet

Indications ²

Consequences of acute cerebral circulation disorders, including those after transient ischemic attacks, in the subcompensation phase as prophylactic courses;
Mild traumatic brain injury, consequences of traumatic brain injury;
Encephalopathies of various origin (dyscirculatory, dysmetabolic, post-traumatic, mixed);
Vegetative dystonia syndrome;
Mild cognitive disorders of atherosclerotic origin;
Anxiety disorders in neurotic and neurosis-like states;
Ischemic heart disease as part of complex therapy;
The relief of withdrawal syndrome in alcoholism with predominant neurosis-like and vegetative-vascular disorders, post-withdrawal disorders;
Status post acute antipsychotic intoxication;
Asthenic conditions, as well as prevention of somatic diseases induced by extreme factors and stress;
Exposure to extreme (stressful) factors;
Attention deficit hyperactivity disorder (ADHD) in children, including hyperactivity, disorder of attention, and impulsiveness.

№40

Mexidol® FORTE 250 film-coated tablets
250 mg

in 1 tablet 250 mg of active substance

Order online General characteristics
of the medicinal product Package leaflet

Indications ³

consequences of acute cerebrovascular accident, including after transient ischemic attacks, in the subcompensation phase as preventive courses;
Mild traumatic brain injury, consequences of traumatic brain injury;
Encephalopathies of various origin (dyscirculatory, dysmetabolic, post-traumatic, mixed);
Vegetative dystonia syndrome;
Mild cognitive disorders of atherosclerotic origin;
Anxiety disorders in neurotic and neurosis-like states;
Ischemic heart disease as part of complex therapy;
The relief of withdrawal syndrome in alcoholism with predominant neurosis-like and vegetative-vascular disorders, post-withdrawal disorders;
Status post acute antipsychotic intoxication;
Asthenic conditions, as well as prevention of somatic diseases induced by extreme factors and stress;
The exposure to extreme (stressful) factors.